Literature DB >> 5303331

The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients.

W H Mosley, S Ahmad, A S Benenson, A Ahmed.   

Abstract

A bacteriological and serological study of family contacts of 81 cholera patients was carried out in Dacca, East Pakistan. In the 10-day follow-up, 78 (16.7%) of 466 contacts were found to be infected with Vibrio cholerae; half of them were symptomatic and 29 had to be admitted to hospital. A study of serum pairs revealed a 4-fold, or greater, rise in titre in 86% of those infected in whom diarrhoea was present, and in 77% of individuals with inapparent infections. The infection rate fell markedly with age. Serological tests for vibriocidal antibody on blood specimens collected at the initiation of the follow-up revealed higher titres with increasing age. Vibrio cholerae infection, whether symptomatic or asymptomatic, predominantly occurred in individuals with low titres.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5303331      PMCID: PMC2554681     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  A serological survey for cholear antibodies in rural east Pakistan. 1. The distribution of antibody in the control population of a cholera-vaccine field-trial area and the relation of antibody titre to the pattern of endemic cholera.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

2.  A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate.

Authors:  W H Mosley; A S Benenson; R Barui
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

3.  Clinical and bacteriological findings among families of cholera patients.

Authors:  R Oseasohn; S Ahmad; M A Islam; A S Rahman
Journal:  Lancet       Date:  1966-02-12       Impact factor: 79.321

4.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  4 in total
  64 in total

1.  Social and news media enable estimation of epidemiological patterns early in the 2010 Haitian cholera outbreak.

Authors:  Rumi Chunara; Jason R Andrews; John S Brownstein
Journal:  Am J Trop Med Hyg       Date:  2012-01       Impact factor: 2.345

Review 2.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

3.  Type-specific action of vibriocidal antibody on Vibrio cholerae.

Authors:  A H Pykett; N W Preston
Journal:  J Hyg (Lond)       Date:  1975-12

4.  Risk Factors for Household Transmission of Vibrio cholerae in Dhaka, Bangladesh (CHoBI7 Trial).

Authors:  Vanessa Burrowes; Jamie Perin; Shirajum Monira; David A Sack; Mahamud-Ur Rashid; Toslim Mahamud; Zillur Rahman; Munshi Mustafiz; Sazzadul I Bhuyian; Farzana Begum; Fatema Zohura; Shwapon Biswas; Tahmina Parvin; Tasdik Hasan; Xiaotong Zhang; Bradley R Sack; K M Saif-Ur-Rahman; Munirul Alam; Christine Marie George
Journal:  Am J Trop Med Hyg       Date:  2017-06       Impact factor: 2.345

5.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

6.  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks.

Authors:  Wilbur H Chen; Richard N Greenberg; Marcela F Pasetti; Sofie Livio; Michael Lock; Marc Gurwith; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

7.  An overview of VaxchoraTM, a live attenuated oral cholera vaccine.

Authors:  Tarun Saluja; Vijayalaxmi V Mogasale; Jean-Louis Excler; Jerome H Kim; Vittal Mogasale
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

Review 8.  Interventions for the control of diarrhoeal diseases among young children: chemoprophylaxis.

Authors:  I de Zoysa; R G Feachem
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  Observed Handwashing with Soap Practices Among Cholera Patients and Accompanying Household Members in a Hospital Setting (CHoBI7 Trial).

Authors:  Fatema Zohura; Sazzadul Islam Bhuyian; Shirajum Monira; Farzana Begum; Shwapon K Biswas; Tahmina Parvin; David Sack; R Bradley Sack; Elli Leontsini; K M Saif-Ur-Rahman; Mahamud-Ur Rashid; Rumana Sharmin; Xiaotong Zhang; Munirul Alam; Christine Marie George
Journal:  Am J Trop Med Hyg       Date:  2016-10-03       Impact factor: 2.345

10.  Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.

Authors:  Jason B Harris; Michael J Podolsky; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Tanya Logvinenko; Jennifer Kendall; Abu S G Faruque; Cathryn R Nagler; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.